<![CDATA[Lysando AG 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=41039>Tue, 21 Apr 2026 12:20:55 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Pharma Leader Dr. Holger Zimmermann Joins Lysando's Advisory Board in Pioneering Fight Against Antibiotic-Resistant Bacteria]]>https://www.newswire.co.kr/newsRead.php?no=978318Thu, 09 Nov 2023 09:50:00 +0900<![CDATA[제약업계의 리더 홀거 짐머만 박사, 항생제 내성 박테리아와 선구적인 싸움을 위해 라이산도 자문위원회 합류]]>https://www.newswire.co.kr/newsRead.php?no=978319Thu, 09 Nov 2023 09:50:00 +0900<![CDATA[Lysando Welcomes Healthcare Visionary Jorge Cortell to its Advisory Board]]>https://www.newswire.co.kr/newsRead.php?no=973909Fri, 08 Sep 2023 10:05:00 +0900<![CDATA[라이산도, 자문 위원으로 헬스케어 분야 선구자 조지 코르텔 임명]]>https://www.newswire.co.kr/newsRead.php?no=973912Fri, 08 Sep 2023 10:05:00 +0900<![CDATA[Artilysin® - A Groundbreaking “Green Pharma” Solution]]>https://www.newswire.co.kr/newsRead.php?no=969384Sun, 25 Jun 2023 13:20:37 +0900<![CDATA[Artilysin® - 획기적인 ‘녹색 제약’ 솔루션]]>https://www.newswire.co.kr/newsRead.php?no=969385Sun, 25 Jun 2023 13:20:10 +0900<![CDATA[Amicogen and Lysando: Novel Approach for the Treatment of Mastitis in Dairy Cows]]>https://www.newswire.co.kr/newsRead.php?no=966577Tue, 09 May 2023 16:55:00 +0900<![CDATA[아미코젠과 라이산도: 젖소 유선염 치료의 새로운 접근법]]>https://www.newswire.co.kr/newsRead.php?no=966578Tue, 09 May 2023 16:55:00 +0900<![CDATA[Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG]]>https://www.newswire.co.kr/newsRead.php?no=965152Fri, 14 Apr 2023 11:00:00 +0900<![CDATA[라이산도 AG, 최고과학책임자에 신용철 박사 임명]]>https://www.newswire.co.kr/newsRead.php?no=965153Fri, 14 Apr 2023 11:00:00 +0900<![CDATA[Artilysin®: Promising Approach Against Acinetobacter baumannii Infected Wounds]]>https://www.newswire.co.kr/newsRead.php?no=962441Thu, 02 Mar 2023 11:10:00 +0900<![CDATA[아틸라이신: 아시네토박터 바우마니균 감염 상치에 대한 유망한 접근법]]>https://www.newswire.co.kr/newsRead.php?no=962442Thu, 02 Mar 2023 11:10:00 +0900<![CDATA[Artilysin®: Fearless Into the Post-antibiotic Era]]>https://www.newswire.co.kr/newsRead.php?no=958098Fri, 16 Dec 2022 11:25:00 +0900<![CDATA[아틸라이신, 두려움 없는 포스트 항생제 시대 열어]]>https://www.newswire.co.kr/newsRead.php?no=958099Fri, 16 Dec 2022 11:25:00 +0900<![CDATA[Lysando AG and Amicogen Inc. Sign General Development Agreement]]>https://www.newswire.co.kr/newsRead.php?no=953701Wed, 19 Oct 2022 11:50:00 +0900<![CDATA[라이산도 AG-아미코젠, 일반 개발 계약 체결]]>https://www.newswire.co.kr/newsRead.php?no=953702Wed, 19 Oct 2022 11:50:00 +0900<![CDATA[Dr. Fabian Geldmacher is Director Strategy & Business Development of Lysando AG]]>https://www.newswire.co.kr/newsRead.php?no=950850Wed, 07 Sep 2022 10:50:00 +0900<![CDATA[라이산도 AG, 신임 전략 및 경영 개발 책임자에 파비안 겔트마허 박사 임명]]>https://www.newswire.co.kr/newsRead.php?no=950851Wed, 07 Sep 2022 10:50:00 +0900<![CDATA[Wilhelm von Haller is Chief Financial Officer of Lysando AG]]>https://www.newswire.co.kr/newsRead.php?no=948994Wed, 03 Aug 2022 11:05:00 +0900<![CDATA[빌헬름 폰 할러, 라이산도 AG 최고재무책임자에 임명]]>https://www.newswire.co.kr/newsRead.php?no=948995Wed, 03 Aug 2022 11:05:00 +0900<![CDATA[Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim]]>https://www.newswire.co.kr/newsRead.php?no=947789Wed, 13 Jul 2022 10:10:00 +0900<![CDATA[라이산도, 김상정 아미코젠 영업·마케팅 이사 영입해 이사회 강화]]>https://www.newswire.co.kr/newsRead.php?no=947790Wed, 13 Jul 2022 10:10:00 +0900